# Effect of Ciprofloxacin Versus Levofloxacin on QTc-interval and Dysglycemia

> **NCT04456712** · PHASE4 · COMPLETED · sponsor: **Beni-Suef University** · enrollment: 200 (actual)

## Conditions studied

- QTc Prolongation, Hyperglycemia, Hypoglycemia

## Interventions

- **DRUG:** Ciprofloxacin 400 MG/200 ML Intravenous Solution
- **DRUG:** Levofloxacin 750 MG

## Key facts

- **NCT ID:** NCT04456712
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-01
- **Primary completion:** 2018-11-30
- **Final completion:** 2018-12-30
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2020-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04456712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04456712, "Effect of Ciprofloxacin Versus Levofloxacin on QTc-interval and Dysglycemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04456712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*